- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1417
Companies which are more than 50% undervalued based on analyst price target.
1,417 companies
CERo Therapeutics Holdings
Market Cap: US$3.9m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$0.65
7D
-23.7%
1Y
-99.5%
Oragenics
Market Cap: US$3.9m
A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.
OGEN
US$0.17
7D
-13.5%
1Y
-90.8%
Galecto
Market Cap: US$3.8m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$2.75
7D
-8.2%
1Y
-83.8%
HeartSciences
Market Cap: US$3.7m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$3.43
7D
-4.8%
1Y
-61.0%
Dragonfly Energy Holdings
Market Cap: US$3.7m
Engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and industrial and energy storage markets.
DFLI
US$0.46
7D
-23.3%
1Y
-95.9%
Quoin Pharmaceuticals
Market Cap: US$3.7m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$6.19
7D
1.5%
1Y
-77.1%
Kazia Therapeutics
Market Cap: US$3.6m
Operates as an oncology-focused biotechnology company in South Korea.
KZIA
US$3.62
7D
-5.2%
1Y
-74.7%
Biodexa Pharmaceuticals
Market Cap: US$3.6m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.41
7D
0.7%
1Y
-93.9%
Alzamend Neuro
Market Cap: US$3.6m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$0.66
7D
-1.8%
1Y
-87.9%
ENDRA Life Sciences
Market Cap: US$3.5m
Develops technologies to improve the capabilities of clinical diagnostic ultrasound.
NDRA
US$3.26
7D
-46.9%
1Y
-99.4%
VivoSim Labs
Market Cap: US$3.4m
A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
VIVS
US$1.90
7D
-5.0%
1Y
-82.9%
Palisade Bio
Market Cap: US$3.4m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.75
7D
-4.8%
1Y
-88.8%
60 Degrees Pharmaceuticals
Market Cap: US$3.3m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$2.39
7D
4.8%
1Y
-82.3%
NovaBay Pharmaceuticals
Market Cap: US$3.3m
Does not have significant operations.
NBY
US$0.56
7D
-3.9%
1Y
-80.0%
CNS Pharmaceuticals
Market Cap: US$3.3m
A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.
CNSP
US$1.14
7D
0.9%
1Y
-99.8%
Artelo Biosciences
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$1.02
7D
0%
1Y
-23.9%
Edible Garden
Market Cap: US$3.3m
Edible Garden AG Incorporated, together with its subsidiaries, operate as a controlled environment agriculture farming company.
EDBL
US$2.25
7D
19.3%
1Y
-97.7%
Tharimmune
Market Cap: US$3.1m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.51
7D
-1.3%
1Y
-73.2%
Eyenovia
Market Cap: US$3.1m
A commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics.
EYEN
US$1.08
7D
-7.7%
1Y
-98.2%
Enveric Biosciences
Market Cap: US$3.1m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$1.28
7D
-0.8%
1Y
-90.4%
Spruce Biosciences
Market Cap: US$3.1m
A biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders.
SPRB
US$0.075
7D
1.0%
1Y
-91.0%
Windtree Therapeutics
Market Cap: US$3.0m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.85
7D
-14.4%
1Y
-99.6%
Ensysce Biosciences
Market Cap: US$2.9m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.17
7D
-15.6%
1Y
-72.4%
Expion360
Market Cap: US$2.9m
Designs, assembles, manufactures, and sells lithium iron phosphate (LiFePO4) batteries and supporting accessories in the United States.
XPON
US$1.01
7D
11.0%
1Y
-99.5%
Pinstripes Holdings
Market Cap: US$2.9m
Operates a dining and entertainment concept restaurants.
PNST
US$0.06
7D
14.7%
1Y
-98.0%
Beneficient
Market Cap: US$2.8m
A technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States.
BENF
US$0.33
7D
10.5%
1Y
-92.9%
Revelation Biosciences
Market Cap: US$2.8m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$3.18
7D
11.1%
1Y
-90.4%
My Size
Market Cap: US$2.7m
An omnichannel e-commerce platform, provides AI-driven software as a service measurement solution for fashion ecommerce companies in Israel and Spain.
MYSZ
US$1.32
7D
3.1%
1Y
-68.3%
Zapp Electric Vehicles Group
Market Cap: US$2.5m
Designs, manufactures, and sells electric vehicles under the Zapp brand.
ZAPP
US$0.40
7D
-14.8%
1Y
-75.7%
Catheter Precision
Market Cap: US$2.4m
Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.
VTAK
US$0.29
7D
5.9%
1Y
-95.2%
Cumulus Media
Market Cap: US$2.3m
An audio-first media company, owns and operates radio stations in the United States.
CMLS
US$0.14
7D
-6.7%
1Y
-94.8%
Bone Biologics
Market Cap: US$2.3m
A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
BBLG
US$0.75
7D
3.8%
1Y
-61.0%
Stryve Foods
Market Cap: US$1.7m
Engages in the manufacture, marketing, and sale of healthy snacking products in North America.
SNAX
US$0.43
7D
-0.07%
1Y
-74.4%
Medicine Man Technologies
Market Cap: US$1.7m
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
SHWZ
US$0.02
7D
0%
1Y
-96.8%
Processa Pharmaceuticals
Market Cap: US$1.4m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.24
7D
3.2%
1Y
-88.6%
Bio-Path Holdings
Market Cap: US$1.4m
Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
BPTH
US$0.16
7D
8.7%
1Y
-94.0%